Qatar partners with US cancer centre to enhance cancer patient care
Qatar partners with US cancer centre to enhance cancer patient care

Doha: Minister of Public Health HE Mansoor bin Ebrahim Al Mahmoud has affirmed Qatar's commitment to attracting the most prominent specialised international centres to support its ongoing efforts to advance cancer patient care.

He said the memorandum of understanding signed on Wednesday between the Ministry of Public Health and Memorial Sloan Kettering Cancer Center would boost significant progress achieved in treatment, research, and disease prevention, while contributing to the delivery of the highest standards of patient care.

Speaking on the sidelines of the signing, the minister said the partnership will enable both parties to enhance cancer patient care in Qatar and the region, and support the development and expansion of scientific research and innovation, in alignment with the priorities of the National Health Strategy and Qatar National Vision 2030.

President and CEO of Memorial Sloan Kettering Cancer Center, Dr. Selwyn M. Vickers, said the proposed partnership will bring over 140 years of clinical excellence, scientific discovery, and innovation to patients in Qatar and the region, delivering an advanced level of cancer care and reinforcing the centre's mission to eradicate cancer for a lifetime.

Chairman of the Board of Trustees of Memorial Sloan Kettering, Scott M. Stuart, said the board continuously evaluates global opportunities that would advance its mission, noting that the proposed partnership has become an institutional priority given that it addresses a significant regional need and aligns with the centre's capabilities and specialised expertise.

The MoU is expected to establish a framework for cooperation in precision medicine, cancer research, and innovation, encompassing genomics, cell therapies, cancer vaccines, antibody-based platforms, and clinical trials. The collaboration involves leveraging advanced cloud computing and artificial intelligence capabilities to support clinical care, scientific research, diagnostics, drug discovery, and innovation in oncology, translating the latest scientific and clinical advancements from MSK into improved treatment options and outcomes for patients receiving care in Qatar.

Join on Rehaab Online WhatsApp Group (Click here to join the group)


Follow Rehaab Online Instagram for More Updates (Click here)

Quick Links

© Rehaab Media Online. All Rights Reserved.